158 related articles for article (PubMed ID: 26386406)
1. Optimization of dilution refolding conditions for a camelid single domain antibody against human beta-2-microglobulin.
Bao X; Xu L; Lu X; Jia L
Protein Expr Purif; 2016 Jan; 117():59-66. PubMed ID: 26386406
[TBL] [Abstract][Full Text] [Related]
2. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
3. A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli.
Xu L; Song X; Jia L
Biotechnol Appl Biochem; 2017 Nov; 64(6):895-901. PubMed ID: 28853185
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
Bu D; Zhou Y; Tang J; Jing F; Zhang W
Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
[TBL] [Abstract][Full Text] [Related]
5. Optimized refolding and characterization of active C-terminal ADAMTS-18 fragment from inclusion bodies of Escherichia coli.
Dang S; Hong T; Bu D; Tang J; Fan J; Zhang W
Protein Expr Purif; 2012 Mar; 82(1):32-6. PubMed ID: 22119775
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152).
Chen LH; Huang Q; Wan L; Zeng LY; Li SF; Li YP; Lu XF; Cheng JQ
Protein Expr Purif; 2006 Apr; 46(2):495-502. PubMed ID: 16243538
[TBL] [Abstract][Full Text] [Related]
7. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies.
Maggi M; Scotti C
Protein Expr Purif; 2017 Aug; 136():39-44. PubMed ID: 28214589
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of three in-vitro refolding methods for human-derived anti-CTLA4 scFv expressed in E. coli].
Huang Q; Chen L; Zeng L; Wan L; Li S; Lu X; Cheng J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):388-91. PubMed ID: 16706373
[TBL] [Abstract][Full Text] [Related]
10. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
Upadhyay V; Singh A; Panda AK
Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
[TBL] [Abstract][Full Text] [Related]
11. Efficient refolding of recombinant reteplase expressed in Escherichia coli strains using response surface methodology.
Fathi-Roudsari M; Maghsoudi A; Maghsoudi N; Niazi S; Soleiman M
Int J Biol Macromol; 2020 Dec; 164():1321-1327. PubMed ID: 32698065
[TBL] [Abstract][Full Text] [Related]
12. Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive.
Kudou M; Ejima D; Sato H; Yumioka R; Arakawa T; Tsumoto K
Protein Expr Purif; 2011 May; 77(1):68-74. PubMed ID: 21195184
[TBL] [Abstract][Full Text] [Related]
13. MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies.
Kuo MM; Nguyen PH; Jeon YH; Kim S; Yoon SM; Choe S
Microb Cell Fact; 2014 Feb; 13(1):29. PubMed ID: 24559319
[TBL] [Abstract][Full Text] [Related]
14. [The study of in vitro refolding conditions for humanized anti-CTLA4-scFv expressed in E. coli].
Zeng L; Huang Q; Chen L; Wan L; Lu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Jun; 22(3):588-92. PubMed ID: 16013266
[TBL] [Abstract][Full Text] [Related]
15. High-yield reactivation of anionic tobacco peroxidase overexpressed in Escherichia coli.
Zakharova GS; Poloznikov AA; Chubar TA; Gazaryan IG; Tishkov VI
Protein Expr Purif; 2015 Sep; 113():85-93. PubMed ID: 25986322
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification, refolding and in vitro recovery of active full length recombinant human gelatinase MMP-9 in Escherichia coli.
Mohseni S; Moghadam TT; Dabirmanesh B; Khajeh K
Protein Expr Purif; 2016 Oct; 126():42-48. PubMed ID: 27164034
[TBL] [Abstract][Full Text] [Related]
17. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
[TBL] [Abstract][Full Text] [Related]
18. Refolding, Crystallization, and Crystal Structure Analysis of a Scavenger Receptor Cysteine-Rich Domain of Human Salivary Agglutinin Expressed in Escherichia coli.
Zhang C; Lu P; Wei S; Hu C; Miyoshi M; Okamoto K; Itoh H; Okuda S; Suzuki M; Kawakami H; Nagata K
Protein J; 2024 Apr; 43(2):283-297. PubMed ID: 38265733
[TBL] [Abstract][Full Text] [Related]
19. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
[TBL] [Abstract][Full Text] [Related]
20. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
